Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 May;134(5):783-7.
doi: 10.1016/j.otohns.2005.12.029.

Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss

Daisuke Aoki  1 , Hideki Takegoshi, Shigeru Kikuchi
Affiliations
Comparative Study

Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss

Daisuke Aoki et al. Otolaryngol Head Neck Surg. 2006 May.

Abstract

Objective: To determine the efficacy of a high-dose steroid regimen for patients with sudden sensorineural hearing loss (SSNHL) and to evaluate the relationship between outcome and initial steroid dose.

Study design and setting: We conducted a retrospective study of 112 patients presenting to Saitama Medical Center. Patients received tapering courses of hydrocortisone (HC) with an initial dose of either 1200 mg or 600 mg.

Results: More than 87% of patients had recovery of hearing. When hearing stabilized, there were no significant differences between the 1200 mg and 600 mg groups in terms of hearing outcome (P>0.05). However, at completion of treatment, the 1200 mg group exhibited significantly superior complete recovery rate and improvement rate (P<0.05).

Conclusion: Application of our treatment protocol of a tapered course of 1200 mg HC significantly and rapidly improves recovery outcomes in patients of SSNHL.

Ebm rating: C-4.

PubMed Disclaimer

Publication types